Comparative analysis of the effects of estrogens and tamoxifen on the brain functions

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 71, Issue 6, 2008, Pages 49-53

  Kazakova, S B ^a   Sapronov, N S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ANXIETY; BRAIN FUNCTION; CLINICAL PRACTICE; COGNITION; COMPARATIVE STUDY; CRYING; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; EMOTION; HORMONAL THERAPY; MOOD DISORDER; REVIEW;

ANIMALS; BRAIN; ESTROGENS; HIGHER NERVOUS ACTIVITY; HUMANS; LIGANDS; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 59149106352     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. J. Bebchuk, C. Arfken, and S. Dolan-Manji, Arch Gen Psychiatry, 95-97 (2000).
11. S. G. Birnbaum, P. X. Yuan, M. Wang, et al., Science, 306, 882 - 884 (2004).
12. M. Bloch, P.J.Schmidt, et al., J. Psychiatry, 157, 924-930 (2005).
13. C. Cathcart, S. Jones, and C. Pumroy, Br. C. Res., Treat., 27, 277-283(1993).
14. M. Cyr, F. Calon, and M. Morisette, Cur. Pharmac. Des., 6, 1287-1312(2000).
15. M. Cyr, F. Calon, and T. Di Paolo, J. Psychyatry Neurosci, 27, 12-27(2002).
16. M. Cyr and T. Di Paolo, Neuropsychopharmacology, 27, 12 - 27(2000).
17. J. M. Daniel, J. K. Sulzer, and J. L. Hulst, Horm. Behav, 49, 38-44(2006).
18. R. Day, J. of the National Cancer Inst, 93(21), 1615-1623 (2001).
19. K. Dhandapani and D. Brann, Biology of Reproduction, 67, 1379-1385(2002).
20. A. Diez-Perez, Arg Bras Endocrinol Metab., 50, 720-734 (2006).
21. M. Dutertre and C. Smith, Pharmacology, 295, 431-437 (2000).
22. J. Eberling, C. Wu, and Tong-Turnbeaugh., Neuroimage, 21(1), 364-371 (2004).
23. H. Einat, P. Yuan, and S. Szabo, Neuropsychobiology, 50, 720-734 (2007).
24. T. Ernst, L. Chang, D. Cooray, et al., JNCI, 94, 592 - 597 (2002).
25. C. J. Gruber and W. Tschugguel, N. Engl. J. Med., 346, 340-352(2002).
26. U. Halbreich, Psychopharmacl. Bull, 26, 291 - 294 (1990).
27. U. Halbreich and S. Wamback, Psychoneuroendocrinology: the scientific basis of cl pr., O. M. Wolkowitz, A. J. Rothschild (eds.), pp. 303 - 320 (2003).
28. V. C. Jordan, Cancer Research., 61, 5683 - 5687 (2001).
29. B. Katzenellenbogen, J. Steroid Biochem Mol Biol, 30, 279-285 (2000).
30. J. Kulkarni, K. Garland, A. Scaffidi, et al., Psychoneuroendocrinology, 31, 543 - 547 (2006).
31. M. Landry and T. Di Paolo, Brain Res Mol Brain Res, 10, 112 (l-2):82-9(2003).
32. M. Le Saux and T. Di Paolo, Rev. Psychiatr. Neurosci., 30, 110- 118(2005).
33. H. Manji and C. A. Zarate, Mol. Psychiatry, 7,1-7 (2002).
34. B. S. McEwen and S. H. Alves, Endocr. Rev., 20, 279-307 (1999).
35. B. S. McEwen, Rec. ProgressHorm. Res, 57,357 - 384 (2002).
36. A. Mize, L. Young, R. Alper, et al., Neuropharmac, 44, 584-591 (2003).
37. D. Mook, J. Felger, and F. Graves, Psychoneuroendocr., 30(3), 273-283 (2005).
38. B. L.Riggs and L. C. Hartmann, N. Engl. J. Med., 348, 618-629(2003).
39. T. A. Richardson and R. D. Robinson, Prim. Care Update Ob. Gyns., 7, 215 - 223 (2000).
40. D. R. Rubinow and P. J. Schmidt, Psychoneuroendocrinology: the scientific basis of cl. pr., O. M. Wolkowitz, A. J. Rothschild (eds.), pp. 245 -272 (2003).
41. M. D. Rubinov and P. J. Schmidt, Psychoneuropharmacology, 10,245 - 273(2006).
42. D. Russel, J. Brian, A. Wang, et al., Neuroendocr., 81, 391-399(2005).
43. I. Silva, L. Mello, E. Freymuller, et al., Neurosci Lett, 291, 183-186(2000).
44. E. Simpson, M. Misso, K. Hewitt, et al., Endocrine Rev., 26, 322-330(2005).
45. B. E. Summer, K. E. Grant, et. al., Mol. Brain Res., 73, 119-128(1999).
46. A. Tavani and C. La Vecchia, Drugs Aging, 14, 347-357 (1999).
47. D. Trent, T. Rovis, et al., Endocrinology, 146,797 - 807 (2005).
48. A. Waif and C. Frye, Neuropsychopharmacol, 30, 1288 - 1301 (2005).
49. A. Waif and C. Frye, Neuropsychopharmacol, 30(9), 1598-1609(2005).
50. A. Waif and C. Frye, Neuropsychopharmacol, 31, 1097 - 111 (2006).
51. L. Weinstock and L. Cohen, Psychoneuroendocrinology: the scientific basis of cl. pr., O. M. Wolkowitz, A. J. Rothschild (eds.), pp. 282 - 301 (2003).
52. A. Yildiz-Yesiloglu, Paris, France: 19th European College of Neuropsychopharmacology, s. 13.02 (2006).
53. J. Zarate, J. Singh, P. Carlson, et al., Bipolar Disoders, 9, 561 - 570 (2007).
54. L. Zhao, K. O'Neill, R. D. Brinton, Br. Res. Rev., 49, 472 - 493 (2005).